Communications, Inc. (NASDAQ: NUAN) today announced that the
American College of Radiology (ACR) and Massachusetts General Hospital
(MGH) will leverage the Nuance PowerShare Network, the industry’s
largest cloud-based medical imaging exchange, to bring clinical
guidelines to the radiologist’s workflow and automate the process of
collecting and reporting quality measures to meet industry regulations
The Medicines Company (NASDAQ:MDCO) will be represented at the American
College of Emergency Physicians (ACEP) Annual Scientific Assembly in
Chicago, which brings together more than 4,000 emergency medical
professionals focused on advancing clinical science that improves the
care for millions of Americans who seek first-line treatment through
emergency rooms across the country’s hospital systems and centers.
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based
biopharmaceutical company focused on the global development and
commercialization of biosimilar monoclonal antibodies, today announced
they will present data from their Phase 3 study, "BOW015, a Biosimilar
Infliximab, in Patients with Active Rheumatoid Arthritis on Stable
Methotrexate Doses: 54-Week Results of a Randomized, Double-Blind,
Active Comparator Study,” at the 2014 Annual Scientific Meeting of the
American College of Rheumatology and the Association of Rheumatology
Health Professionals (ACR/ARHP), November 18, in Boston, MA.
Pharmaceuticals, Inc. (NASDAQ: IRWD) and Actavis
plc (NYSE: ACT) announced today that the following
linaclotide-related data will be presented during the American College
of Gastroenterology 2014 Annual Scientific Meeting in Philadelphia,
October 17 through October 22, 2014.
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that
four company-sponsored abstracts evaluating the safety and efficacy of
albuterol multi-dose dry-powder inhaler (MDPI), an investigational
breath-actuated, dry-powder, short-acting beta-agonist (SABA), will be
presented at the 2014 Annual Scientific Meeting of the American College
of Allergy, Asthma & Immunology (ACAAI) in Atlanta, Georgia on November
Sign-up for Teva Presents Data for Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) at 2014 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology investment picks
(NYSE: AZN) today presented top-line results of two pivotal Phase III
trials investigating the potential of lesinurad, a selective uric acid
re-absorption inhibitor (SURI), when used in combination with xanthine
oxidase (XO) inhibitor allopurinol.
The Medicines Company (NASDAQ: MDCO) today announced the presentation of
the results of the pivotal Phase III clinical trial of the
investigational hemostatic agent RAPLIXA™ (fibrin sealant), formerly
known as Fibrocaps, at the 100 th Clinical Congress of the
American College of Surgeons in San Francisco, CA.
Sign-up for The Medicines Company Announces Presentation of Investigational Hemostatic Agent RAPLIXA™ (fibrin sealant) Phase III FINISH-3 Trial Results at the 2014 Clinical Conference of the American College of Surgeons investment picks
Squibb Company (NYSE:BMY) announced today that 16 abstracts for Orencia
were accepted for presentation at the 2014 annual meeting of the
American College of Rheumatology (ACR) taking place from November 14-19,
2014 in Boston, MA.
Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today the presentation
of initial data from a Phase IIa clinical study in functional dyspepsia
with IW-9179, an investigational guanylate cyclase-C (GC-C) agonist
designed to target the upper gastrointestinal (GI) tract.
Sign-up for Data From Phase 2b Clinical Trial of Clazakizumab, an Anti-IL-6 Monoclonal Antibody for the Treatment of Active Psoriatic Arthritis, to be Presented at the American College of Rheumatology Annual Meeting investment picks
- 37 abstracts evaluating HUMIRA and investigational medicines in rheumatologic diseases - New data presented on ABT-122, an investigational novel protein that targets TNF and IL-17
NORTH CHICAGO, Ill.
Sign-up for Can-Fite CEO Dr. Pnina Fishman to Present Recently Released Positive Data from its Rheumatoid Arthritis Phase IIb Study at the 2014 American College of Rheumatology Annual Meeting investment picks
Sign-up for Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting investment picks
Premium Membership: Features and Benefits
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.